This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Houston System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Bradley K McConnell in Viral Infection Treatment
Introduction
Bradley K McConnell is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of antiviral research, particularly in developing compounds that can effectively treat or prevent viral infections. His work is crucial in the ongoing battle against various viruses, including coronaviruses.
Latest Patents
Bradley K McConnell holds a patent for "Small molecules that treat or prevent viral infections." This invention relates to anti-viral compounds that are designed to block virus entry into cells. The methods described in the patent involve associating cells with these anti-viral compounds, which can occur either in vitro or in vivo. The administration of these compounds aims to treat or prevent viral infections in subjects, particularly humans who are suffering from or are vulnerable to such infections. Notably, the patent addresses viruses like the severe acute respiratory syndrome-related coronavirus 2 (SARS-COV-2).
Career Highlights
Bradley K McConnell is affiliated with the University of Houston System, where he continues to advance his research in antiviral compounds. His work has garnered attention for its potential impact on public health, especially in light of recent global health challenges.
Collaborations
Some of his notable coworkers include Arfaxad Reyes Alcaraz and John W Craft. Their collaborative efforts contribute to the innovative research environment at the University of Houston System.
Conclusion
Bradley K McConnell's innovative work in developing antiviral compounds represents a significant advancement in the fight against viral infections. His contributions are vital for improving treatment options and enhancing public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
